DSS, Inc. (DSS)
| Market Cap | 25.54M |
| Revenue (ttm) | 42.40M |
| Net Income (ttm) | -93.10M |
| Shares Out | 140.26M |
| EPS (ttm) | -0.70 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 72,387 |
| Open | 0.191 |
| Previous Close | 0.185 |
| Day's Range | 0.182 - 0.191 |
| 52-Week Range | 0.149 - 0.468 |
| Beta | 1.89 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2023 |
About DSS
DSS, Inc. operates in the product packaging, biotechnology, direct, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy businesses. It manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advan... [Read more]
Financial Performance
In 2022, DSS, Inc.'s revenue was $47.31 million, an increase of 133.33% compared to the previous year's $20.28 million. Losses were -$59.84 million, 80.7% more than in 2021.
Financial StatementsNews
DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary
Jim Monaghan Appointed Chief Operating Officer and Chief Compliance Officer; Michael Cheah Joins as Portfolio Manager and Head of Fixed Income Jim Monaghan Appointed Chief Operating Officer and Chief ...
DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc.
DSS Shareholders of Record on July 10, 2023 to Receive Four Shares of Impact Biomedical Inc. for Every One Share of DSS, Inc. DSS Shareholders of Record on July 10, 2023 to Receive Four Shares of Impa...
DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.
ROCHESTER, N.Y., July 05, 2023 (GLOBE NEWSWIRE) -- DSS Wealth, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce the appointment o...
DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.
Shareholders of Record on July 10, 2023 to Receive Four Shares of Impact Biomedical Inc. for Every One Share of DSS, Inc. on a Future Distribution Date Shareholders of Record on July 10, 2023 to Recei...
DSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special Dividend
DSS Shareholders of Record on June 30 to Receive 4 Shares for Every 1 DSS Share DSS Shareholders of Record on June 30 to Receive 4 Shares for Every 1 DSS Share
DSS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
ROCHESTER, N.Y., May 16, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and ...
DSS Inc. Announces Distribution Date of Sharing Services Shares to DSS Shareholders
Distribution Date of May 4, 2023 Set for Stock Dividend of Sharing Services Shares (SHRG) Distribution Date of May 4, 2023 Set for Stock Dividend of Sharing Services Shares (SHRG)
DSS, Inc. Announces Plan to Distribute Common Stock of Sharing Services Global Corporation to Shareholders
ROCHESTER, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions an...
DSS, Inc. to Present at Emerging Growth Conference April 19 at 1:45 PM
Company to Highlight Strong Revenue Growth and Planned Spinoffs to DSS Shareholders Company to Highlight Strong Revenue Growth and Planned Spinoffs to DSS Shareholders
DSS Announces Letter to Shareholders
CEO Highlights Business Plan including Spin-Offs CEO Highlights Business Plan including Spin-Offs
DSS Receives New York Stock Exchange Notice Regarding Late Form 10-Q Filing
ROCHESTER, N.Y., Aug. 30, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets ...
DSS Announces Licensing of Impact BioMedical's Linebacker Portfolio to ProPhase Labs
ROCHESTER, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets ...
DSS Strengthens and Expands Board with Appointment of Two Independent Directors
ROCHESTER, N.Y., July 13, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets ...
Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir
HENRIETTA, N.Y., June 28, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS), along with its scientific research partner Global Research and ...
DSS's Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito Repellant
China is one of the leading markets globally for insect repellants China is one of the leading markets globally for insect repellants
DSS, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®
ROCHESTER, N.Y., May 06, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets t...
CORRECTION - DSS Announces Letter to Shareholders
ROCHESTER, N.Y., Feb. 28, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by DSS, Inc. (NYSE American: DSS), please note that in paragraph fourteen, [With more than ...
DSS to Present at Aegis Virtual Conference
ROCHESTER, N.Y., Feb. 22, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth industrie...
DSS Receives $17 Million Investment from Alset EHome International
ROCHESTER, N.Y., Jan. 25, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth industrie...
DSS Shareholder Alset EHome To Raise Stake To 55.52%
DSS Inc (NYSE: DSS) has entered a stock purchase agreement with its shareholder Alset EHome International Inc. (AEI), which owns 15.24% of its outstanding shares. Under the agreement, AEI sold 877.24 ...
DSS Acquires 25.1% of Alset International Limited
DSS adds True Partner Capital with $1.7B AUM into DSS Securities; greatly enhancing the portfolio of the finance and asset management division of DSS
DSS Expands American Medical REIT Subsidiary with Acquisition of 21,900 Sq. Ft. Medical Office Building
Six years remaining on lease for primary tenant at Winter Haven, Florida property Six years remaining on lease for primary tenant at Winter Haven, Florida property
Impact BioMedical Announces New Bioplastics Test Results
ROCHESTER, N.Y., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS) along with its scientific research partner Global Research and D...
DSS Provides Update on Expansion of Premier Packaging Subsidiary
New 105,000 sq. ft. facility more than doubles Premier's capacity to produce sustainable fiber-based packaging solutions for a wide variety of consumer products New 105,000 sq. ft. facility more than ...
DSS's American Pacific Bancorp Approaches $20M in New Loans Issued
ROCHESTER, N.Y., Dec. 20, 2021 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth industrie...